SunTrust Starts Intra-Cellular Therapies (ITCI) at Buy
Tweet
Share
E-mailGet Alerts ITCI Hot Sheet
Price: $73.12 -1.2%
Rating Summary:
17 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
17 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
SunTrust Robinson Humphrey initiated coverage on Intra-Cellular Therapies (NASDAQ: ITCI) with a Buy rating and a price target of $50.00.
For an analyst ratings summary and ratings history on Intra-Cellular Therapies click here. For more ratings news on Intra-Cellular Therapies click here.
Shares of Intra-Cellular Therapies closed at $21.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intra-Cellular Therapies (ITCI) PT Raised to $107 at Canaccord Genuity
- CLSA Starts Yokohama Rubber Co (5101:JP) at Underperform (4)
- Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
The Children's Investment Fund (TCI), SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
